International Clinical Trial: Clinical Efficacy of Methylprednisolone Sodium Succinate for Injection in the Treatment of Patients with Moderate to Severe Traumatic Brain Injury: A Multicenter, Randomized Controlled, Double-Blind Trial

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118252) titled 'Clinical Efficacy of Methylprednisolone Sodium Succinate for Injection in the Treatment of Patients with Moderate to Severe Traumatic Brain Injury: A Multicenter, Randomized Controlled, Double-Blind Trial' on Feb. 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First People's Hospital of Zhangjiagang City

Condition: Traumatic Brain Injury

Intervention: Control Group:Placebo [2 mg/kg administered intravenously in 100 mL normal saline (maximum dose not exceeding 160 mg), once daily for 5 consecutive days].

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enroll...